BioAdvance Revenue and Competitors
Estimated Revenue & Valuation
- BioAdvance's estimated annual revenue is currently $10.1M per year.
- BioAdvance's estimated revenue per employee is $155,000
Employee Data
- BioAdvance has 65 Employees.
- BioAdvance grew their employee count by -2% last year.
BioAdvance's People
Name | Title | Email/Phone |
---|---|---|
1 | Partner | Reveal Email/Phone |
2 | Partner | Reveal Email/Phone |
BioAdvance Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $2.8M | 18 | -33% | N/A | N/A |
#10 | $9.1M | 59 | -9% | N/A | N/A |
What Is BioAdvance?
BioAdvance is a biotechnology company based out of United States.
keywords:N/AN/A
Total Funding
65
Number of Employees
$10.1M
Revenue (est)
-2%
Employee Growth %
N/A
Valuation
N/A
Accelerator
BioAdvance News
2022-04-19 - Global Blood-Brain Barrier Transport Drugs Market to See ...
Cyclenium, BioAdvance, EIP Pharma, Bioasis Ripon College Days...
2022-04-17 - Adge Pharma, Cyan Bio advance treatments for rare ...
Adge Pharma, Cyan Bio advance treatments for rare paediatric diseases in Asian countries. 26 April 2022 | News...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $14.7M | 65 | 2% | N/A |
#2 | $5.9M | 65 | 16% | N/A |
#3 | $16.3M | 65 | 3% | N/A |
#4 | $12.9M | 65 | -23% | N/A |
#5 | $12.9M | 65 | 35% | N/A |